XERIS PHARMACEUTICALS INC (XERS) has 55 open-market insider trades by 20 insiders since 2018. The most active filer is Paul R. Edick.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Deerfield Mgmt III, L.P. via James E. Flynn | 10% Owner | — | 1 | $11.3M | 2018-06-25 |
| Redmile Group, LLC via Jeremy Green | 10% Owner | — | 1 | $10.0M | 2018-06-25 |
| Jeremy Green | 10% Owner | — | 1 | $5.9M | 2019-02-19 |
| James E. Flynn | 10% Owner | — | 2 | $3.7M | 2019-01-29 |
| Palmetto Partners 2014, LP | 10% Owner | — | 1 | $2.3M | 2018-06-25 |
| John Johnson | Dir | — | 2 | $1.8M | 2026-06-04 |
| Paul R. Edick | — | — | 10 | $1.5M | 2024-01-31 |
| Steven Prestrelski | CSO | — | 6 | $1.1M | 2023-01-31 |
| John Patrick Shannon Jr. | — | — | 7 | $813K | 2026-08-01 |
| Jeffrey W. Sherman | Dir | — | 2 | $679K | 2025-08-28 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Beth Hecht | — | Sell | $157K | 2026-10-01 |
| Steven Pieper | — | Sell | $47K | 2026-10-01 |
| Kevin McCulloch | — | Sell | $141K | 2026-10-01 |
| Kevin McCulloch | — | Sell | $250K | 2026-09-28 |
| Steven Pieper | — | Sell | $43K | 2026-09-01 |
| Beth Hecht | — | Sell | $141K | 2026-09-01 |
Companies that share insiders with XERS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Kevin McCulloch | — | Sell | $127K | 2026-09-01 |
| Steven Pieper | — | Sell | $43K | 2026-08-12 |
| Kevin McCulloch | — | Sell | $120K | 2026-08-03 |
| Beth Hecht | — | Sell | $134K | 2026-08-03 |
| Steven Pieper | — | Sell | $383K | 2026-07-06 |
| Beth Hecht | — | Sell | $134K | 2026-07-01 |
| Kevin McCulloch | — | Sell | $723K | 2026-07-01 |
| John Johnson | Director | Sell | $91K | 2026-06-04 |
| Barbara-jean Anne Bormann-kennedy | Director | Sell | $98K | 2026-06-04 |